Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ufp Technologies ( (UFPT) ) just unveiled an update.
On February 19, 2026, UFP Technologies, through a wholly owned subsidiary, amended its long-standing Manufacturing Supply Agreement with strategic medical customer Intuitive Surgical, effective January 1, 2026. The amendment extends the contract term by two years to December 31, 2029 and materially raises minimum annual volumes for the largest program in 2028 and 2029, while adding an additional program under the agreement.
The revised agreement also introduces volume-based pricing tied to minimum purchase thresholds and cost-sharing provisions, aligning incentives between the parties. The changes signal deeper integration with a key medical customer and could enhance revenue visibility for UFP Technologies, though the company notes that actual purchase volumes and its ability to sustain higher production levels remain subject to operational and customer demand risks.
The most recent analyst rating on (UFPT) stock is a Hold with a $278.00 price target. To see the full list of analyst forecasts on Ufp Technologies stock, see the UFPT Stock Forecast page.
Spark’s Take on UFPT Stock
According to Spark, TipRanks’ AI Analyst, UFPT is a Outperform.
UFP Technologies’ strong financial performance and strategic focus on high-margin opportunities in the medical device market are significant strengths. However, mixed technical indicators and operational challenges, particularly labor inefficiencies, present risks. The company’s moderate valuation and future growth prospects in MedTech and robotic surgery are promising, but current challenges need to be addressed to fully realize potential.
To see Spark’s full report on UFPT stock, click here.
More about Ufp Technologies
UFP Technologies, Inc. is a manufacturing company that supplies specialized components to the medical sector, including strategic programs for major healthcare technology customers. Its business is anchored in long-term manufacturing and supply agreements that support customers’ evolving volume and program needs in advanced medical applications.
Average Trading Volume: 159,692
Technical Sentiment Signal: Buy
Current Market Cap: $1.9B
For an in-depth examination of UFPT stock, go to TipRanks’ Overview page.